Sign In
Buy IONS
$73.82
+0.85 (+1.16%)
At Close: Jun 03, 2026
Ionis Pharmaceuticals Inc (NASDAQ:IONS) Stake Lifted by Commonwealth Equity Services LLC
06:44am, Wednesday, 10'th Jun 2020
Commonwealth Equity Services LLC increased its stake in Ionis Pharmaceuticals Inc (NASDAQ:IONS) by 3.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchang
Acadian Asset Management LLC Sells 1,907 Shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS)
05:52am, Wednesday, 10'th Jun 2020
Acadian Asset Management LLC lessened its stake in Ionis Pharmaceuticals Inc (NASDAQ:IONS) by 63.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and
-$0.22 Earnings Per Share Expected for Ionis Pharmaceuticals Inc (NASDAQ:IONS) This Quarter
05:20am, Wednesday, 10'th Jun 2020
Equities research analysts expect Ionis Pharmaceuticals Inc (NASDAQ:IONS) to report earnings of ($0.22) per share for the current quarter, according to Zacks Investment Research. Six analysts have mad
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
11:00am, Tuesday, 09'th Jun 2020
Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Kia Motesharei, Ph.D., has joined the company as Senior Vice President of Busin
The global Polymerase Chain Reaction Market size is expected to reach USD 8.14 billion by 2026, on account of the advent of digitalization and the gradual shift
Ionis Pharmaceuticals to present at upcoming virtual investor conferences
11:05am, Friday, 05'th Jun 2020
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in antisense therapeutics, today announced that management will present a company overview at the following virtual investor conferences:
Avidity Biosciences Starts U.S. IPO Plan (Pending:RNA)
07:20pm, Monday, 01'st Jun 2020
Avidity Biosciences has filed to raise $100 million in an IPO, although the final figure may differ. The firm is development treatments for various muscular dys
Got $3,000? Here Are 3 Great Biotech Stocks to Buy Right Now
11:03am, Friday, 29'th May 2020
While the broader market indexes are still down year to date despite strong rebounds in recent weeks, the major biotech exchange-traded funds (ETFs) are in solid positive territory for the year. Gran
Edited Transcript of IONS earnings conference call or presentation 6-May-20 3:30pm GMT
05:50am, Friday, 29'th May 2020
Q1 2020 Ionis Pharmaceuticals Inc Earnings Call
Ionis Pharmaceuticals to host 2020 virtual annual meeting of stockholders
08:05pm, Thursday, 28'th May 2020
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2020 virtual Annual Meeting of Stockholders and provide a general corporate update on Thursday, June 4, 2020
Results from the ongoing, open-label extension (OLE) study of the pivotal NEURO-TTR trial published in the European Journal of Neurology show that patients treated with TEGSEDI®.
Ionis Pharmaceuticals Inc. (NASDAQ: IONS) Q1 2020 Earnings Call Transcript | AlphaStreet
03:47pm, Wednesday, 27'th May 2020
Final earnings conference call transcript of Ionis Pharmaceuticals Inc. - IONS stock
Ionis: Uncertain Revenues Hamper Valuation. Share Price Can Gain On Spinraza, Pipeline (NASDAQ:IONS)
08:41pm, Wednesday, 20'th May 2020
Ionis share price is down 21% year on year, falling from $66 to $52. In March '19, the stock had traded at all-time highs of $85. The company earns revenues fro
Estimating The Intrinsic Value Of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
01:07pm, Tuesday, 19'th May 2020
How far off is Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) from its intrinsic value? Using the most recent financial...
Akcea Announces Appointment of New Chief Financial Officer
11:00am, Monday, 18'th May 2020
Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Michael D. Price has joined the company as executive vice president and chief f
